Table 3.
Details of the 13 relapsing patients.
| Histology | Timing (mo) | Pattern of 1st relapse | Laterality | No of pulmonary nodules | Size of the largest pulmonary nodule (mm) | Detection mode | Treatment with curative intent | Status at FU (mo) |
|---|---|---|---|---|---|---|---|---|
| Sarcoma NOS | 2 | Pulmonary | Bi | 4 | 9 | ULD-CT | No | DOD (26 mo) |
| Sarcoma NOS | 2 | Pulmonary | Bi | 12 | 12 | ULD-CT+CXR | No | DOD (7 mo) |
| UPS | 4 | Pulmonary | Mono | 4 | 5 | ULD-CT | SBRT | NED (54 mo) |
| Myxofibrosarcoma | 4 | Pulmonary | Mono | 1 | 9 | ULD-CT+CXR | Surgery | DOD (12 mo) |
| Liposarcoma | 6 | Pulmonary | Mono | 1 | 7 | ULD-CT | Surgery | DOD (31 mo) |
| Sarcoma NOS | 6 | Pulmonary | Mono | 1 | 14 | ULD-CT+CXR | Surgery | DOD (30 mo) |
| Liposarcoma | 6 | Pulmonary and other sites and LR | Bi | > 10 | 5 | ULD-CT | No | DOD (3 mo) |
| Leiomyosarcoma | 10 | Pulmonary | Bi | 9 | 6 | ULD-CT | No | DOD (48 mo) |
| Leiomyosarcoma | 14 | Pulmonary | Mono | 1 | 6 | ULD-CT | Surgery | DOD (30 mo) |
| Leiomyosarcoma | 27 | Pulmonary and other sites | Bi | 61 | 5 | symptoms | No | AWD (27 mo) |
| Angiosarcoma | 10 | Other sites* | symptoms | No | DOD (1 mo) | |||
| Myxofibrosarcoma | 35 | LR and lymph node | MRI | Surgery and XRT | DOD (21 mo) | |||
| Myxofibrosarcoma | 12 | LR | MRI | Surgery and XRT | NED (36 mo) |
AWD alive with disease, CXR chest radiograph, FU follow-up, DOD dead of disease, LR local recurrence, nd no data, MRI magnetic resonance imaging, NED no evidence of disease, NOS not otherwise specified, SBRT stereotactic body radiotherapy, ULD-CT ultra-low-dose computed tomography, UPS undifferentiated pleomorphic sarcoma, XRT radiation therapy.
*liver and spleen.